A61K36/577

COMPOSITIONS CONTAINING PLANT MUCILAGE
20250360076 · 2025-11-27 ·

A body lubricating, moisturizing, anti-inflammatory, and anti-pain formulation utilizes a mucilage-containing extract derived from a plant such as okra, Abelmoschus esculentus (Hibiscus esculentus). The formulation can be provided as a free liquid such as a solution, suspension, foam, gel, cream, ointment, or spray or alternatively impregnated into an absorbent solid article such as a mask, a wipe, swab, a bandage, cloth pad or a gauze. Application of the formulation to a mucosal or external bodily tissue result in the application of a layer of mucilage that lubricates and moisturizes the tissue as well as protects it from external damage from foreign particles and UV irradiation. Application of the formulation to an inflamed tissue provides anti-inflammatory effects and relieves pain.

COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF PREPARATION AND USE THEREOF
20250367220 · 2025-12-04 · ·

Compositions that include cannabinoids other than tetrahydrocannabinol (THC), such as cannabigerol (CBG) in combination with tetrahydrocannabinol (THC) or formulated to be combined with THC, and methods of preparation and use thereof are described. The compositions may be useful to reduce the risk of THC-induced anxiety and/or to produce a different intoxicating effect compared to THC alone.

Powdered plant preparation, the manner in which it is obtained, microgranules and tablets obtained from that preparation and the ways of producing them

Disclosed is a powdered plant preparation and a method for its preparation, as well as microgranules and tablets obtained therefrom, and methods for their preparation. The invention is suitable for use in the production of herbal preparations.

COMPOSITION FOR PREVENTING, IMPROVING, OR MITIGATING KIDNEY-DEFICIENCY-ASSOCIATED SYMPTOMS OR CONDITIONS OF SKIN, HAIR, AND NAILS

A composition includes the following active components: component (1): at least one selected from the group consisting of Ligustrum fruit, yerbadetajo herb, Lilium bulb, Polygonatum Rhizome, Lycium fruit, Sesamum indicum, and black soybean; component (2): at least one selected from the group consisting of Suberect spatholobus stem, Longan aril, wild turmeric, zedoary root, Luffa vegetable sponge, Sparganium rhizome, safflower, Artemisia anomala, common fenugreek seed, Dipsacus japonicus root, Drynaria herb, sea horse, Cynomorium herb, and Astragalus Seed; component (3): at least one selected from the group consisting of tea leaf, plantago seed, plantago herb, coix seed, small red-bean, corn silk, Lophatherum herb, Benincasa seed, mallow seed, knotgrass, and Lygodium spore; and component (4): at least one selected from the group consisting of Dioscorea japonica Thunberg, Eleutherococcus senticosus Rhizome, honey, oriental bush cherry, ginger root, ripe tangerine peel, unripe tangerine peel, immature orange, malt starch syrup, jujube fruit, and non-glutinous rice.

INHALANT DEVICE
20260083807 · 2026-03-26 ·

Provided is a formulation useful for treating sore throat, throaty cough, xerostomia, pharyngitis, laryngitis, postoperative pain, dysphagia, laryngeal granuloma, vocal optimization, laryngopharyngeal reflux or dysbiosis, wherein the formulation comprises: an aqueous solution comprising one or more active ingredients selected from the group consisting of marshmallow root, slippery elm extract, aloe vera extract, manuka honey, honey, holy basil, menthol, spearmint, capsaicin, propolis, curcumin, xylitol, turmeric, probiotics, and calendula, the aqueous solution being present as aerosolized particles in a range of 10 to 35 microns.

COMPOSITIONS AND METHODS FOR AMELIORATING SYMPTOMS ASSOCIATED WITH INFLAMMATORY SKIN DISORDERS

The present invention is directed to compositions and methods for ameliorating symptoms associated with inflammatory skin disorders involving applying a synergistic blend of plant-based actives containing: (1) a synergistic blend of at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; (c) a biotech-derived Haberlea rhodopensis extract; and (d) Padina pavonica thallus extract; and (2) at least one skin protectant active ingredient.

Compositions and methods for ameliorating symptoms associated with inflammatory skin disorders

The present invention is directed to compositions and methods for ameliorating symptoms associated with inflammatory skin disorders involving applying a synergistic blend of plant-based actives containing: (1) a synergistic blend of at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; (c) a biotech-derived Haberlea rhodopensis extract; and (d) Padina pavonica thallus extract; and (2) at least one skin protectant active ingredient.

Topical skin care formulations comprising plant extracts
12605308 · 2026-04-21 · ·

A method for treating skin of a person in need thereof is disclosed. The method includes topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Ficus lacor, wherein the extract from Ficus lacor reduces oxidation in the skin or reduces MMP-1 activity in the skin.

COMPOSITION AND METHOD FOR INHIBITING COLLAGENASE ACTIVITY
20260124132 · 2026-05-07 ·

A composition for administration to a subject is disclosed. The composition comprises at least one botanical active component. The botanical active component is present in the composition in an amount effective to inhibit collagenase activity in the skin of the subject. The botanical active component comprises at least one extract selected from the group consisting of: i) an extract of Potentilla glabra leaf; ii) an extract of Bombax malabaricum flower; iii) an extract of Amomum kravanh fruit; iv) an extract of Cornus officinalis fruit; and v) combinations of i) to iv). The composition may be in the form of a topical composition, e.g., for topical application. The composition may also be in the form of an oral composition, e.g., for ingestion. A method of inhibiting collagenase activity in the skin of a subject is also provided. The method comprises administering an effective amount of the composition to the subject.